Maryland Biotech’s Big Challenge
This article was originally published in The Pink Sheet Daily
Executive Summary
CEOs from start-up companies based in Maryland discuss how they achieve growth.
You may also be interested in...
Advancis Files NDA For Pulsatile Amoxicillin
The company does not rule out the possibility of copromoting the first once-daily formulation of the antibiotic as a way of expanding its sales force if Amoxicillin Pulsys is approved.
Cancer-Genomics Firm Quanticel Debuts With Close Ties To Celgene, And An Exit In Mind
Celgene will get exclusive use of Quanticel's single-cell genomic analysis to tweak its clinical pipeline, and it also has exclusive options to acquire the venture-backed start-up.